Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood

Last updated: August 23, 2017
Sponsor: IRCCS Burlo Garofolo
Overall Status: Trial Not Available

Phase

3

Condition

Pain (Pediatric)

Chronic Pain

Pain

Treatment

N/A

Clinical Study ID

NCT00557544
rc 32/07
  • Ages 6-17
  • All Genders

Study Summary

This is a Randomized double blind trial with the aim to estimate the effectiveness of 3 therapeutic regimes per os on migraine pain:

  • metoclopramide 0,15 mg/kg + placebo

  • metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg

  • ketoprofen 1 mg/Kg + placebo

Intensity of pain will be measured with linear 1-10 scale or analogic McGrath type scale every 20 min.

The main objective is the evaluation of healing times from pain in the 3 groups

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Children 6-17 years old with migraine presenting in emergency room

Exclusion

Exclusion Criteria:

  • Informed consensus not obtained

  • Occurring migraine still treated

  • Hemiplegic migraine

Study Design

Study Start date:
June 01, 2009
Estimated Completion Date:
June 30, 2010

Connect with a study center

  • Edoardo Guglia

    Trieste, 34100
    Italy

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.